Usana Health Sciences Inc (USNA) (Q3 2026) Earnings Call Highlights: Haya Subscriber Growth
Usana Health Sciences (USNA) reported Q3 2026 earnings, highlighting growth in Southeast Asia Pacific and Haya subscriber growth. The company discussed incentive plans, marketing strategies, and new product launches. Haya's net sales outlook was raised to $130 million. Core nutrition sales grew 2% YoY in Southeast Asia, but active customers declined 8% YoY overall. The full-year net sales outlook was adjusted to $900 million, with adjusted EBITDA of $77 million.
How this was made
The 30-second read
Why it matters
Guidance downgrade and mixed regional results suggest near‑term downside risk, but growth initiatives may provide upside later.
Market read
Usana's updated guidance is the primary new information, affecting its valuation and potentially influencing the nutrition‑supplement sector.
What to watch
Strong Haya subscriber growth and upcoming product launches could offset margin concerns in the longer term.
Background
Usana Health Sciences held its Q3 2026 earnings call, discussing regional performance, incentive plan changes, and product pipeline.
Ticker impact
Usana Health Sciences provided updated full‑year outlook of $900M net sales and $77M adjusted EBITDA, down from prior $80.5M EBITDA guidance.
downward pressure as investors price in lower EBITDA guidance
The new EBITDA target is materially below prior expectations, a key profitability metric for a mid‑cap consumer‑health company.
Market effects
Potential drag on the broader nutrition and supplement sector as peers may face similar margin pressures.
Southeast Asia growth noted, but Greater China weakness could affect regional exposure.
Limited to consumer‑health niche; unlikely to move broader indices.
Counterpoint
If the new incentive plan drives strong customer retention, the guidance cut may be temporary and the stock could rebound.
Key entities
- ExecutiveKevin Guest
CEO of Usana, provided outlook and commentary on growth initiatives.
- ExecutiveDoug Hekking
CFO of Usana, disclosed revised full‑year financial guidance.
